Sfoglia per Autore
Genetic evolution of human metapneumovirus fusion protein
2008-01-01 Massimo, Ciccozzi; Marco, Ciotti; Chiara, Minini; Stefania, Montieri; Paola, Apostoli; Limongi, D; CARLO FEDERICO, Perno; Arnaldo, Caruso; Simona, Fiorentini
Qual è la metodica migliore per monitorare il CMV nei pazienti trapiantati di cellule staminali ematopoietiche?
2008-01-01 Paba, P; Ciotti, M; Guenci, T; Giannella, S; Marcuccilli, F; Serafini, V; Limongi, D; DI MONTE, S; Ronga, L; Fabeni, L; Greco, F; Perno, Cf
Comparison of the eSwab collection and transportation system to an amies gel transystem for Gram stain of clinical specimens
2009-01-01 Fontana, C; Favaro, M; Limongi, D; Pivonkova, J; Favalli, C
AKT Activation is Associated with Sustained Virologic Response (SVR) After Treatment with Pegylated Interferon-alfa and Ribavirin (PEG-IFN+RBV) in Patients with Chronic Hepatitis C
2010-01-01 Aybike, Birerdinc; Maria, Stepanova; Limongi, D; Arian, Afendy; Mariaelena, Pierobon; Issah, Younossi; Lance, Liotta; Ancha, Baranova; Emanuel F., Petricoin; Zobair M., Younossi
Protein Pathway Biomarkers Predicting Sustained Virologic Response (SVR) to Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) in Treatment-Naive Genotype 1 Patients with Chronic Hepatitis C (CH-C)
2010-01-01 Limongi, D; Stepanova, ; Maria, ; Afendy, ; Arian, ; Pierobon, ; Mariaelena, ; Agrawal, ; Ritambhara, ; Liotta, ; Lance, ; Petricoin, ; Emanuel, ; Younossi, ; Zobair, M.
Protein pathway biomarkers predicting sustained virologic response (SVR) to Pegylated interferon (PEG-IFN) and Ribavirin (RBV) in patients with chronic hepatitis C (CH-C).
2010-01-01 Z., Younossi; Limongi, D; M., Stepanova; M., Pierobon; A., Afendy; L., Liotta; E., Petricoin.
Protein pathway biomarker signature associated with superimposed non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with chronic hepatitis C
2010-01-01 M., Stepanova; Limongi, D; A., Afendy; M., Pierobon; I., Younossi; T., Gramlich; L., Liotta; E., Petricoin; Z., Younossi
Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV)
2011-01-01 Younossi, Zm; Limongi, D; Stepanova, M; Pierobon, M; Afendy, A; Mehta, R; Baranova, A; Liotta, L; Petricoin, E
Intracellular Redox Signaling as Therapeutic Target for Novel Antiviral Strategy
2011-01-01 Nencioni, L; Sgarbanti, R; Amatore, D; Checconi, P; Celestino, I; Limongi, D; Anticoli, S; Palamara, At; Garaci, E
Influenza Virus And Intracellular Redox State: Characterization Of Redox-Sensitive Molecular Targets For Innovative Antiviral Strategies
2012-01-01 Sgarbanti, R; Amatore, D; Limongi, Dolores; L, Nencioni; Baldelli, S; Aquilano, K; Ciriolo, Mr; Garaci, E; Palamara, At
Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males
2012-01-01 Torcia, Mg; Nencioni, L; Clemente, Am; Civitelli, L; Celestino, I; Limongi, D; Fadigati, G; Perissi, E; Cozzolino, F; Garaci, E; Palamara, At
A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes
2013-01-01 Chirullo, B; Sgarbanti, R; Limongi, D; Shytaj, Il; Alvarez, D; Das, B; Boe, A; Dafonseca, S; Chomont, N; Liotta, L; Iii Petricoin, E; Norelli, S; Pelosi, E; Garaci, E; Savarino, A; Palamara, At
The environmental pollutant cadmium promotes influenza virus replication in MDCK cells by altering their redox state
2013-01-01 Checconi, Paola; Rossella, Sgarbanti; Celestino, Ignacio; Limongi, Dolores; Amatore, Donatella; Alessandra, Iuvara; Alessandro, Alimonti; Enrico, Garaci; Palamara, ANNA TERESA; Nencioni, Lucia
Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS
2014-01-01 Amatore, D; Sgarbanti, R; Aquilano, K; Baldelli, S; Limongi, D; Civitelli, L; Nencioni, L; Garaci, E; Ciriolo, Mr; Palamara, At.
The Shigella flexneri OspB effector: an early immunomodulator
2015-01-01 Ambrosi, Cecilia; Pompili, Monica; Scribano, Daniela; Limongi, Dolores; Petrucca, Andrea; Cannavacciuolo, Sonia; Schippa, Serena; Zagaglia, Carlo; Grossi, Milena; Nicoletti, Mauro
The Shigella flexneri OspB effector: an early immunomodulator
2015-01-01 Ambrosi, C; Pompili, M; Scribano, D; Limongi, D; Petrucca, A; Cannavacciuolo, S; Schippa, S; Zagaglia, C; Grossi, M; Nicoletti, M.
New sepsis biomarkers
2016-01-01 Limongi, D; D'Agostini, C; Ciotti, M
Redox Imbalance and Viral Infections in Neurodegenerative Diseases
2016-01-01 Limongi, D; Baldelli, S
A Novel Method to Titrate Herpes Simplex Virus-1 (HSV-1) Using Laser-Based Scanning of Near-Infrared Fluorophores Conjugated Antibodies
2017-01-01 Fabiani, M; Limongi, D; Palamara, At; De Chiara, G; Marcocci, Me
Serum thymosin alpha 1 levels in normal and pathological conditions
2018-01-01 Pica, F; Gaziano, R; Casalinuovo, Ia; Moroni, G; Buè, C; Limongi, D; D'Agostini, C; Tomino, C; Perricone, R; Palamara, At; Sinibaldi Vallebona, P; Garaci, E
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Genetic evolution of human metapneumovirus fusion protein | 1-gen-2008 | Massimo, Ciccozzi; Marco, Ciotti; Chiara, Minini; Stefania, Montieri; Paola, Apostoli; Limongi, D; CARLO FEDERICO, Perno; Arnaldo, Caruso; Simona, Fiorentini | |
Qual è la metodica migliore per monitorare il CMV nei pazienti trapiantati di cellule staminali ematopoietiche? | 1-gen-2008 | Paba, P; Ciotti, M; Guenci, T; Giannella, S; Marcuccilli, F; Serafini, V; Limongi, D; DI MONTE, S; Ronga, L; Fabeni, L; Greco, F; Perno, Cf | |
Comparison of the eSwab collection and transportation system to an amies gel transystem for Gram stain of clinical specimens | 1-gen-2009 | Fontana, C; Favaro, M; Limongi, D; Pivonkova, J; Favalli, C | |
AKT Activation is Associated with Sustained Virologic Response (SVR) After Treatment with Pegylated Interferon-alfa and Ribavirin (PEG-IFN+RBV) in Patients with Chronic Hepatitis C | 1-gen-2010 | Aybike, Birerdinc; Maria, Stepanova; Limongi, D; Arian, Afendy; Mariaelena, Pierobon; Issah, Younossi; Lance, Liotta; Ancha, Baranova; Emanuel F., Petricoin; Zobair M., Younossi | |
Protein Pathway Biomarkers Predicting Sustained Virologic Response (SVR) to Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) in Treatment-Naive Genotype 1 Patients with Chronic Hepatitis C (CH-C) | 1-gen-2010 | Limongi, D; Stepanova, ; Maria, ; Afendy, ; Arian, ; Pierobon, ; Mariaelena, ; Agrawal, ; Ritambhara, ; Liotta, ; Lance, ; Petricoin, ; Emanuel, ; Younossi, ; Zobair, M. | |
Protein pathway biomarkers predicting sustained virologic response (SVR) to Pegylated interferon (PEG-IFN) and Ribavirin (RBV) in patients with chronic hepatitis C (CH-C). | 1-gen-2010 | Z., Younossi; Limongi, D; M., Stepanova; M., Pierobon; A., Afendy; L., Liotta; E., Petricoin. | |
Protein pathway biomarker signature associated with superimposed non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with chronic hepatitis C | 1-gen-2010 | M., Stepanova; Limongi, D; A., Afendy; M., Pierobon; I., Younossi; T., Gramlich; L., Liotta; E., Petricoin; Z., Younossi | |
Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV) | 1-gen-2011 | Younossi, Zm; Limongi, D; Stepanova, M; Pierobon, M; Afendy, A; Mehta, R; Baranova, A; Liotta, L; Petricoin, E | |
Intracellular Redox Signaling as Therapeutic Target for Novel Antiviral Strategy | 1-gen-2011 | Nencioni, L; Sgarbanti, R; Amatore, D; Checconi, P; Celestino, I; Limongi, D; Anticoli, S; Palamara, At; Garaci, E | |
Influenza Virus And Intracellular Redox State: Characterization Of Redox-Sensitive Molecular Targets For Innovative Antiviral Strategies | 1-gen-2012 | Sgarbanti, R; Amatore, D; Limongi, Dolores; L, Nencioni; Baldelli, S; Aquilano, K; Ciriolo, Mr; Garaci, E; Palamara, At | |
Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males | 1-gen-2012 | Torcia, Mg; Nencioni, L; Clemente, Am; Civitelli, L; Celestino, I; Limongi, D; Fadigati, G; Perissi, E; Cozzolino, F; Garaci, E; Palamara, At | |
A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes | 1-gen-2013 | Chirullo, B; Sgarbanti, R; Limongi, D; Shytaj, Il; Alvarez, D; Das, B; Boe, A; Dafonseca, S; Chomont, N; Liotta, L; Iii Petricoin, E; Norelli, S; Pelosi, E; Garaci, E; Savarino, A; Palamara, At | |
The environmental pollutant cadmium promotes influenza virus replication in MDCK cells by altering their redox state | 1-gen-2013 | Checconi, Paola; Rossella, Sgarbanti; Celestino, Ignacio; Limongi, Dolores; Amatore, Donatella; Alessandra, Iuvara; Alessandro, Alimonti; Enrico, Garaci; Palamara, ANNA TERESA; Nencioni, Lucia | |
Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS | 1-gen-2014 | Amatore, D; Sgarbanti, R; Aquilano, K; Baldelli, S; Limongi, D; Civitelli, L; Nencioni, L; Garaci, E; Ciriolo, Mr; Palamara, At. | |
The Shigella flexneri OspB effector: an early immunomodulator | 1-gen-2015 | Ambrosi, Cecilia; Pompili, Monica; Scribano, Daniela; Limongi, Dolores; Petrucca, Andrea; Cannavacciuolo, Sonia; Schippa, Serena; Zagaglia, Carlo; Grossi, Milena; Nicoletti, Mauro | |
The Shigella flexneri OspB effector: an early immunomodulator | 1-gen-2015 | Ambrosi, C; Pompili, M; Scribano, D; Limongi, D; Petrucca, A; Cannavacciuolo, S; Schippa, S; Zagaglia, C; Grossi, M; Nicoletti, M. | |
New sepsis biomarkers | 1-gen-2016 | Limongi, D; D'Agostini, C; Ciotti, M | |
Redox Imbalance and Viral Infections in Neurodegenerative Diseases | 1-gen-2016 | Limongi, D; Baldelli, S | |
A Novel Method to Titrate Herpes Simplex Virus-1 (HSV-1) Using Laser-Based Scanning of Near-Infrared Fluorophores Conjugated Antibodies | 1-gen-2017 | Fabiani, M; Limongi, D; Palamara, At; De Chiara, G; Marcocci, Me | |
Serum thymosin alpha 1 levels in normal and pathological conditions | 1-gen-2018 | Pica, F; Gaziano, R; Casalinuovo, Ia; Moroni, G; Buè, C; Limongi, D; D'Agostini, C; Tomino, C; Perricone, R; Palamara, At; Sinibaldi Vallebona, P; Garaci, E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile